RNA Transfection Kit for Common Cells
Satreda LNP8006
Empowering the Future of Regenerative Medicine
By combining high payload capacity, efficient delivery, low toxicity, and broad applicability, the Satreda LNP8006 kit empowers researchers to unlock the full potential of RNA-based applications in stem cell biology, regenerative medicine, and advanced therapeutic development.
High Efficiency with Low Cytotoxicity
Unlike traditional methods that may compromise cell health or require labor-intensive protocols, LNP8006 employs a non-viral, biodegradable lipid system that ensures robust intracellular RNA delivery while maintaining high cell viability. This provides researchers with reliable data and reduces experimental variability caused by cytotoxic effects.
Ready-to-Use Simplicity
LNP8006 combines ready-to-use convenience with state-of-the-art LNP precision. RNA encapsulation is completed in just one minute — compared to the 10+ hours often required by conventional methods — dramatically streamlining laboratory workflows while delivering superior performance.
Making Advanced RNA Delivery Accessible
The result is a powerful and accessible solution that brings cutting-edge RNA delivery technology to everyday lab use. With LNP8006, scientists can confidently pursue projects in gene silencing, gene editing, vaccine research, and more, knowing they are backed by a kit that delivers both efficiency and reproducibility.
High Cell Expression: LNP8006 leverages advanced transmembrane transport and endosomal escape mechanisms to achieve efficient intracellular delivery, consistently reaching transfection efficiencies above 90%.
Optimized for Common Cell Lines
Specifically designed for HEK293, HeLa, HCT116, L929, and other common cell lines, LNP8006 achieves remarkably high transfection efficiency across diverse RNA modalities, including mRNA, siRNA, gRNA, circRNA, and saRNA. Its broad applicability makes it a versatile tool for gene expression studies, functional genomics, RNA therapeutics research, and high-throughput screening.
24-well plate transfection with eGFP mRNA; fluorescence imaging and flow cytometry at 24 h post-transfection.
Transfection with 30 nM Cy3-labeled siRNA per well; fluorescence imaging at 6 h post-transfection.
